Podcast 46: Does Genetic Testing for Clotting Mutations Matter? An interview with Jodi Segal of Johns Hopkins

You’d think that a widely-ordered test would play a part in management and outcome, but two clotting mutations seem exceptions to that rule. Although often requested, the FDA-approved tests for Factor V Leiden and G20210A mutations don’t seem to figure greatly in case management of venous thromboembolism, at least according to the published literature. Dr. Jodi Segal and her team published a meta-analysis in JAMA this week, and she’s here to discuss the results.

This week’s links:

News–

• CDC Counsels Infection-Control Vigilance to Prevent H1N1 in Health Workers
• Zicam Nasal Cold Remedies Linked to Loss of Sense of Smell
• Stents Not Associated with Improved Function in Renal Artery Stenosis
• Leukotriene Modifiers for Asthma Associated with Neuropsychiatric Adverse Events

Interview links–

• Does Testing for Clotting Mutations Improve Outcomes in VTE?
• Agency for Healthcare Research and Quality (AHRQ)

The post Podcast 46: Does Genetic Testing for Clotting Mutations Matter? An interview with Jodi Segal of Johns Hopkins first appeared on Clinical Conversations.